Similar Search Results

Competition between originators and generics : public regulation and incentives to innovate

Campion, Marie-Geneviève - 2015

on the articulations between regulation and incentives to innovate. Once the characteristics of regulation in …-containment measures and innovation issues is performed, then in the second chapter, an empirical study is performed to investigate … price for off-patent markets can contribute in promoting innovation. Finally, in the fourth chapter, the modeling of risk …

Persistent link: https://www.econbiz.de/10011432290

‘Me-too’ innovation in pharmaceutical markets

Jena, Anupam B.; Calfee, John Edward; Mansley, Edward C.; … - In: Forum for health economics & policy : an evolving … 12 (2009) 1, pp. 1-19

Persistent link: https://www.econbiz.de/10009622061

Public debate : the US food and drug administration and new drug approvals ; a safety vs. innovation paradox?

Hemphill, Thomas A. - In: Innovation: organization & management : IOM 15 (2013) 3, pp. 364-367

Persistent link: https://www.econbiz.de/10010226637

Inbound open innovation for pharmaceutical markets : a case study of an anti-diabetic drug in-licensing decision

Wu, Allan Ya-Huan; Little, Victoria Janine; Low, Brian - In: The journal of business & industrial marketing 31 (2016) 2, pp. 205-218

Persistent link: https://www.econbiz.de/10011486501

Pharmaceutical innovation and parallel trade

Bennato, Anna Rita; Valletti, Tommaso M. - In: International journal of industrial organization 33 (2014), pp. 83-92

Persistent link: https://www.econbiz.de/10010462784

Pioneering advantage in generic drug competition

Yu, Yu; Gupta, Sachin - In: International journal of pharmaceutical and healthcare … 8 (2014) 2, pp. 126-150

Persistent link: https://www.econbiz.de/10010388964

Market size in innovation : theory and evidence from the pharmaceutical industry

Acemoglu, Daron; Linn, Joshua - 2003

Persistent link: https://www.econbiz.de/10001815746

Innovation im Arzneimittelmarkt

Klauber, Jürgen (ed.); Bausch, Jürgen (contributor); … - 2000

Persistent link: https://www.econbiz.de/10001486392

Generics and new goods in pharmaceutical price indexes: comment

Feenstra, Robert C. - In: The American economic review 87 (1997) 4, pp. 760-767

Persistent link: https://www.econbiz.de/10001226839

Pioneering Advantage in Generic Drug Competition

Yu, Yu - 2014

Pharmaceutical markets experience the entry of numerous generic firms upon expiration of the brand firm's patent. In this paper, we take a close look at competition among the generic entrants during the first three years after patent expiration and examine whether there is a first mover...

Persistent link: https://www.econbiz.de/10012709667